PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pharmacy, Federal University of Sergipe, São Cristóvão, Sergipe, Brazil.\', \'Postgraduate Program in Pharmaceutical Sciences, Federal University of Sergipe, São Cristóvão, Sergipe, Brazil.\', \'Department of Pharmacy, Federal University of Sergipe, Lagarto, Sergipe, Brazil.\', \'Postgraduate Program in Pharmaceutical Sciences, Federal University of Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil.\', \'Escola de Saúde e Bem Estar UniRitter, Faculdade de Farmácia - Laureate International Universities, Porto Alegre, Rio Grande do Sul, Brazil.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1080/03639045.2021.1908343
?:hasPublicationType
?:journal
  • Drug development and industrial pharmacy
is ?:pmid of
?:pmid
?:pmid
  • 33826439
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.519
?:rankingScore_hIndex
  • 73
is ?:relation_isRelatedTo_publication of
?:title
  • Mapping the technological landscape of SARS, MERS, and SARS-CoV-2 vaccines.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33826439>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33826439>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all